Specialized Proteins May Be Detected In Alzheimer's Patients' Blood

Specialized Proteins Detected In Alzheimer's Patients' Blood
Specialized brain proteins that are involved in the removal of damaged nerve cell materials may be detected in the blood of people who were diagnosed with mild cognitive impairment or dementia due to Alzheimer's disease. In a selected group of people who later developed dementia, the levels of the lysosomal proteins were abnormal while the people still had no problems with memory or thinking skills, according to a study published in the journal Neurology.
For the study, blood samples were taken from 20 people who later developed Alzheimer's disease up to 10 years before they were diagnosed and then after they were diagnosed. Blood was also taken once from 26 people with Alzheimer's disease and 16 people with frontotemporal dementia, which leads to changes in personality or behavior, and also may affect the memory. In addition, blood samples were taken from 46 healthy people who did not have any problems with thinking or memory skills as a control group.
The researchers looked at four proteins in blood exosomes that come from lysosomes. Lysosomes act as a sort of recycling and disposal center for cells. In each case, the level of protein was significantly different for the healthy controls than for those with dementia - both before and after symptoms developed. For three of the proteins, the people with dementia had significantly higher levels, for one of the proteins the people with dementia had significantly lower levels. For example, for many proteins with a ubiquitin "tail", or unfolded portion, the healthy controls had average levels of 200 picograms per mL, while the people with Alzheimer's disease had average levels of about 375 picograms per mL.
The results could potentially lead to useful biomarkers in diagnosing Alzheimer's disease at an early stage. While the researchers believe that these results will help improve our understanding of how lysosomes function in Alzheimer's disease, as well as how the brain responds to the developing disease, the results need to be confirmed with larger studies.
Based on material originally posted by American Academy of Neurology.